Private Equity Will Make A Killing On Natural Gas… You Can Too

Private Equity Will Make A Killing On Natural Gas… You Can Too by Justin Bennett, Editor No doubt about it, the past two years have been a complete disaster for many natural gas exploration and production (E&P) companies. With the price of their product falling through the floor, producers are taking it on the chin. Revenues are sinking, margins are getting mauled, and balance sheets are broken- all due to the remarkable collapse in natural gas prices. Take a look…. -------------Sponsor------------- The Must-See Video You Cannot Afford To Ignore... In this must-see video, "The Sage of Silicon Valley" offers his latest multimillionaire predictiono.  Over the past 10 years he has accurately predicted and profited from every major market move.  Find out what micro-niche asset could jump 700% in the coming months.  He might be the only one talking about it. Watch the video now or kick yourself later. ------------------------------------ As you can see, it's been nothing but pain for natural gas bulls in recent years. Abundant supplies have the commodity trading at decade low prices. How are natural gas producers coping? It's survival of the fittest right now. Low prices are pressuring companies into selling their natural gas assets. Producers are dumping gas acreage at fire sale prices to shore up their books. They're also divesting natural gas acreage so they have cash to buy oil and natural gas liquids properties… a more profitable venture. Who would want to buy depressed natural gas acreage? Smart money is all over it… Private equity firms Blackstone Group LP (BX), KKR & C0. (KKR), and Apollo Global Management (APO) are all on the hunt for cheap natural gas assets. These sharks smell blood in the water, and they're going on a feeding frenzy. According to the Wall Street Journal, the first quarter of 2012 saw $11 billion in private equity oil and gas transactions… the highest level in the past 20 years. Why are these firms going ga-ga for gas? Private equity realizes the deeply depressed natural gas pricing situation will right itself at some point. Surging demand from utilities, growing transportation usage, and recently approved export terminals all point to higher natural gas prices in the long run. Once prices return to a normalized level (which they will), private equity firms will be sitting on a natural gas gold mine. What does private equity's natural gas buying spree mean for investors like you? There are a slew of natural gas E&Ps trading at cheap, beaten down prices right now. It's tempting to go on a shopping spree like the private equity firms I just mentioned. But this is one investment arena where you have to be extremely careful. Minefields are abundant in natural gas E&P investing right now. But if you know what to look for, there's enormous profit potential as well. As a matter of fact, there is a bunch of gas producers priced below $10.00 right now. But there are only a select few I'm confident will make it out of the current natural gas price depression in one piece. And once they do, investors who scooped up shares at today's bargain basement prices will be rewarded heftily. Unfortunately, I can't reveal which companies are at the top of my buy list. These high profit potential ideas are reserved for subscribers to the The Energy Investor. But the good news is, another issue of my flagship energy service comes out next week. In it, I'm revealing my favorite gas E&P stock that's ready to rocket higher when natural gas rebounds. If you'd like to discover which stocks have the most profit potential in today's tricky natural gas environment, click here. Until Next Time, Justin Bennett

Issue Date: Friday, May 11, 2012 •  Archer Daniels Midland (ADM) popped to a new 52-week high of $33.98. Their market cap is now over $22 billion. •  Aeroflex Holdings (ARX) plunged to a new 52-week low of $6.41. Their market cap is now $608 million. •  Marriot Vacations Worldwide (VAC) ran to a new 52-week high of $31.56. They have a market cap of over $1 billion. "Investors have very short memories."                       -Roman Abramovich Company Sym Gain Vertex Pharma VRTX 57% Feihe International ADY 54% StarTek SRT 48% GTSI Corp. GTSI 45% Arena Pharma ARNA 40% *Week-to-Date, Stock Price > $2 Company Sym Loss MEMSIC MEMS 51% Body Central Corp. BODY 48% Fossil FOSL 41% MAKO Surgical MAKO 40% Silicon Graphics SGI 34% *Week-to-Date, Stock Price > $2 The Spread Trader: Bear Put Spread On Morgan Stanley (MS) Wednesday, May 9, 2012 Three Reasons Why I'm Not Buying The Facebook IPO Monday, May 7, 2012 Sell In May And Go Away? Don't Even Think About It Friday, May 4, 2012

Copyright 2012 Hyperion Financial Group, LLC. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This email may only be used pursuant to the subscription agreement controlling use of the Dynamic Wealth Report website and any reproduction, copying, or redistribution of this email or its contents, in whole or in part, is strictly prohibited without the express written permission of Hyperion Financial Group, LLC. LEGAL DISCLAIMER: Neither Hyperion Financial Group LLC nor any of its employees are a registered investment advisor or a Broker/Dealer. As such, Hyperion Financial Group, LLC does not offer or provide personalized investment advice. Although Hyperion Financial Group, LLC employees may answer general customer service questions, they are not licensed under securities laws to address your particular investment situation. Nothing in this report, nor any communication by our employees to you should be considered personalized investment advice. Owners and writers may have positions in the securities that are discussed. However, no associated employees may intentionally engage in any transaction that directly or indirectly competes with the interests of our subscribers. We accept no compensation from any companies mentioned in our reports. Past performance is no guarantee of future results. All information is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell any security. All opinions, analyses and information contained herein are based on sources believed to be reliable and written in good faith, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. Investments recommended in this publication should only be made after consulting with your financial advisor. Any brokers mentioned herein constitute a partial list of available brokers and is for your information only. We do not recommend or endorse any brokers, dealers, or investment advisors.

This message was sent to ignoble.experiment@arconati.us from: Hyperion Financial | 20701 N Scottsdale Rd, Ste 107-154 | Scottsdale, AZ 85255

Email Marketing by

Manage Your Subscription  |  Forward To a Friend